1. Academic Validation
  2. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1

Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1

  • Cancer Lett. 2007 May 8;249(2):294-9. doi: 10.1016/j.canlet.2006.09.009.
David Kessel 1 John J Reiners Jr
Affiliations

Affiliation

  • 1 Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA. dhkessel@med.wayne.edu
Abstract

L1210 murine leukemia cells exposed to an LD(90) concentration of the Bcl-2/Bcl-x(L) antagonist HA14-1 rapidly undergo Apoptosis but also develop numerous intracellular vacuoles with double membranes, exhibit enhanced labeling by monodansylcadaverine, and convert the cytosolic protein LC3-I to LC3-II. These are hallmarks of Autophagy. Autophagic vacuoles develop rapidly, preceding the appearance of an apoptotic nuclear morphology and can be observed in both non-apoptotic and apoptotic cells. Inhibition of Autophagy by the PI 3-kinase inhibitor wortmannin promoted apoptosis; conversely inhibition of Caspase-3/7 with zDEVD-fmk promoted Autophagy. Neither process was dependent on calcium translocation. These results indicate that pharmacological suppression of Bcl-2 function can mimic the induction of Autophagy that can occur following the down-regulation of Bcl-2 expression by molecular approaches.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-12011
    ≥98.0%, Bcl-2 Family Inhibitor